ScinoPharm Taiwan Ltd 2023 SR
The report highlights ScinoPharm Taiwan's 2023 sustainability performance, focusing on its role as a leading API supplier. Key achievements include passing U.S. FDA inspections with zero 483 observations for its injectable plant and completing its first product carbon footprint verification for Irinotecan Hydrochloride. The company committed to the Science-Based Targets initiative (SBTi) and set a goal to reduce Scope 1 and 2 emissions by 4.2% annually. Socially, it collaborated with the Bill & Melinda Gates Foundation to optimize contraceptive manufacturing and engaged in local placemaking activities. Governance-wise, the company maintained high board independence and achieved 80% female representation in senior management.
Company: ScinoPharm Taiwan Ltd
Sector: Health Care
Country: Taiwan
Year: 2023
Type: SR
Pages: 114
ScinoPharm Taiwan Ltd
Sustainability Report
The report highlights ScinoPharm Taiwan's 2023 sustainability performance, focusing on its role as a leading API supplier. Key achievements include passing U.S. FDA inspections with zero 483 observations for its injectable plant and completing its first product carbon footprint verification for Irinotecan Hydrochloride. The company committed to the Science-Based Targets initiative (SBTi) and set a goal to reduce Scope 1 and 2 emissions by 4.2% annually. Socially, it collaborated with the Bill & Melinda Gates Foundation to optimize contraceptive manufacturing and engaged in local placemaking activities. Governance-wise, the company maintained high board independence and achieved 80% female representation in senior management.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Women on Board
Women in Management
Workplace Fatalities
Employees